Chlamydia trachomatis, NAA
Also known as: Chlamydia, PCR, Uriprobe®
Use
Detect Chlamydia trachomatis
Special Instructions
The test requires specific collection methods depending on the specimen type, including endocervical, vaginal, male urethral swabs, first-void urine, or cervical cells in a liquid cytology vial. Collection requires precise handling as instructed, and the test should be ordered as per the provider's discretion. Proper labeling and transport are critical to avoid specimen rejection.
Limitations
The test's sensitivity may be reduced if specimen collection instructions are not followed properly, particularly with regard to specimen volume and patient preparation. Improper collection or transport can lead to false-negative results. The test cannot determine the antimicrobial susceptibility of the detected pathogen, and results need to be interpreted in the context of clinical findings. The assay should not be used as the sole criterion for the diagnosis of Chlamydia trachomatis infections.
Methodology
PCR-based (Nucleic acid amplification)
Biomarkers
LOINC Codes
- 43304-5
- 43304-5
Result Turnaround Time
2-3 days
Related Documents
For more information, please review the documents below
Specimen
Cervical Swab
Volume
One swab
Minimum Volume
One swab
Container
Gen-Probe® Aptima® swab
Collection Instructions
Remove excess mucus from the cervical os and surrounding mucosa using the cleaning swab. Insert the specimen collection swab into the endocervical canal, rotate gently for 10 to 30 seconds, and place the swab into the transport tube.
Storage Instructions
Room temperature
Causes for Rejection
Specimen with incorrect patient identification; unlabeled specimen; inappropriate specimen transport conditions; specimen leaked in transit; specimen in expired transport or incorrect transport device.